Fidelity Investments’s Yarrow Bioscience YARW Stock Holding History

Fidelity Investments’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Hold	0	–	-$17	–	5709
2024 Q4	–	Hold	0	–	–	–	5395
2022 Q1	–	Sell	-2	Closed	-$2K	–	5529
2021 Q4	$2K	Hold	2	–	–	﹤0.01%	4058
2021 Q3	$2K	Buy	+2	New	+$3.88K	﹤0.01%	4058
2019 Q1	–	Hold	0	–	-$1K	–	4266
2018 Q4	–	Hold	0	–	–	–	3433
2018 Q3	–	Sell	-311	Closed	-$9.08M	–	3822
2018 Q2	$9.08M	Hold	311	–	–	﹤0.01%	1974
2018 Q1	$42M	Buy	+311	New	+$37.8M	0.01%	1384

Other funds holding YARW

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

PSC

Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Fidelity Investments's YARW Position: Q1 2025 in Review

Fidelity Investments held its Yarrow Bioscience (YARW) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5709.

Fidelity Investments first reported a position in YARW in Q1 2018 and has held it in 4 quarters since. The position peaked at $42M in Q1 2018. 38 funds tracked by Wall St. Rank hold YARW as of Q1 2025.

Fidelity Investments held 0 shares of Yarrow Bioscience worth $0 as of Q1 2025.
Fidelity Investments left its Yarrow Bioscience share count unchanged in Q1 2025.
Yarrow Bioscience made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2025, its #5709 holding.
Fidelity Investments first reported a position in Yarrow Bioscience in Q1 2018 and has held it in 4 quarters since.
Fidelity Investments's Yarrow Bioscience position peaked at $42M in Q1 2018.
38 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.